Oryzon Genomics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
July 24, 2023 at 12:47 pm EDT
Oryzon Genomics S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net income was USD 1.15 million compared to USD 0.347 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
For the six months, net loss was USD 0.617 million compared to USD 1.35 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.